secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avery Dennison Corp (AVY)
CIK:        0000008818
Form:       8-K
Filed at:   2024-11-15T23:59:59+00:00
Accession:  0000008818-24-000019
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avery Dennison CFO Gregory Lovins takes medical leave; Danny Allouche named Interim CFO
--------------------------------------------------------------------------------

- CFO Gregory Lovins began medical leave Nov 14, 2024; ceased as principal financial officer.
- Danny Allouche appointed SVP and Interim CFO effective Nov 15, retains Chief Strategy role.
- Allouche's compensation unchanged: base salary ~$450k, target incentive 50% annual, 120% long-term.
- Allouche served as SVP Chief Strategy and Corporate Development since Aug 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/8818/000000881824000019/0000008818-24-000019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/8818/000000881824000019/avy-20241114.htm
  HTML page:      https://secwatch.observer/filing/0000008818-24-000019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer